Literature DB >> 28456699

Cutoff Value and Long-Term Prediction of Clinical Events by FFR Measured Immediately After Implantation of a Drug-Eluting Stent in Patients With Coronary Artery Disease: 1- to 3-Year Results From the DKCRUSH VII Registry Study.

Sui-Ji Li1, Zhen Ge2, Jing Kan2, Jun-Jie Zhang2, Fei Ye2, Tak W Kwan3, Teguh Santoso4, Song Yang5, Imad Sheiban6, Xue-Song Qian7, Nai-Liang Tian2, Tanveer S Rab8, Ling Tao9, Shao-Liang Chen10.   

Abstract

OBJECTIVES: This study aimed to investigate the cutoff of post-drug-eluting stent (DES) fractional flow reserve (FFR) for prediction of 1- to 3-year target vessel failure (TVF).
BACKGROUND: FFR immediately after a DES implantation correlates with clinical events. However, the cutoff of post-DES FFR for predicting long-term clinical events remains understudied.
METHODS: Between May 2012 and September 2013, a total of 1,476 patients who had FFR <0.8 at maximal and at baseline underwent DES implantation were prospectively studied in 9 centers. Post-DES FFR was repeat measured. The primary endpoint was the 1-year TVF rate after procedures. Receiver-operating characteristic curves were used to calculate the post-DES FFR value for TVF, then patients were classified on the basis of this value and followed up for 3 years.
RESULTS: By the end of the first year, 88 (6.0%) TVFs were recorded. A post-DES FFR ≤0.88 strongly correlated with TVF. Disease in the left anterior descending coronary artery (LAD), stent length, and stent diameter were independent factors of impaired post-DES FFR, whereas post-procedure FFR ≤0.88 was the only predictor of TVF, with 40 (4.0%) TVFs in the FFR >0.88 and 48 (8.0%) in the FFR ≤0.88 group (p = 0.001), mainly driven by target vessel revascularization (3.8% vs. 8.8%; p = 0.005) and cardiac death (0.2% vs. 1.3%; p = 0.017). The difference in TVF between 2 groups was maintained through 3-year follow-up (p = 0.002). For patients with LAD lesions, a post-DES FFR ≤0.905 predicted 1-year TVF.
CONCLUSIONS: Post-DES FFR strongly correlated with TVF rate. Mechanisms attributed to and treatments for impaired FFR after stenting should be studied in future studies. (Post-DES FFR Predicts the Clinical Outcomes: DK CRUSH-VII, A Prospective, Multicenter, Registry Study [DK CRUSH-VII]; ChiCTR-PRCH-12001976).
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  drug-eluting stent; fractional flow reserve; percutaneous coronary intervention; revascularization; target vessel failure

Mesh:

Substances:

Year:  2017        PMID: 28456699     DOI: 10.1016/j.jcin.2017.02.012

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  18 in total

Review 1.  Consensus document for invasive coronary physiologic assessment in Asia-Pacific countries.

Authors:  Hak Seung Lee; Joo Myung Lee; Chang-Wook Nam; Eun-Seok Shin; Joon-Hyung Doh; Neng Dai; Martin K C Ng; Andy S C Yong; Damras Tresukosol; Ajit S Mullasari; Rony Mathew; Praveen Chandra; Kuang-Te Wang; Yundai Chen; Jiyan Chen; Kai-Hang Yiu; Nils P Johnson; Bon-Kwon Koo
Journal:  Cardiol J       Date:  2019-06-21       Impact factor: 2.737

2.  Prognostic Implications of Prestent Pullback Pressure Gradient and Poststent Quantitative Flow Ratio in Patients Undergoing Percutaneous Coronary Intervention.

Authors:  Neng Dai; Sheng Yuan; Kefei Dou; Rui Zhang; Nan Hu; Jining He; Changdong Guan; Tongqiang Zou; Zheng Qiao; Shaofeng Duan; Lihua Xie; Yongfu Yu; Yingmei Zhang; Bo Xu; Junbo Ge
Journal:  J Am Heart Assoc       Date:  2022-06-03       Impact factor: 6.106

3.  Clinical implication of QFR in patients with ST-segment elevation myocardial infarction after drug-eluting stent implantation.

Authors:  Jiani Tang; Jiapeng Chu; Hanjing Hou; Yan Lai; Shengxian Tu; Fei Chen; Yian Yao; Zi Ye; Yanhua Gao; Yu Mao; Shaowei Zhuang; Xuebo Liu
Journal:  Int J Cardiovasc Imaging       Date:  2020-10-12       Impact factor: 2.357

4.  Triglyceride to high-density lipoprotein cholesterol ratio as a risk factor of repeat revascularization among patients with acute coronary syndrome after first-time percutaneous coronary intervention.

Authors:  Ya-Min Su; Rui Zhang; Rong-Feng Xu; Hong-Lei Wang; Hai-Hua Geng; Min Pan; Yang-Yang Qu; Wen-Jie Zuo; Zhen-Jun Ji; Gen-Shan Ma
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

5.  Agreement of Angiography-Derived and Wire-Based Fractional Flow Reserves in Percutaneous Coronary Intervention.

Authors:  Hu Ai; Naixin Zheng; Le Li; Guojian Yang; Hui Li; Guodong Tang; Qi Zhou; Huiping Zhang; Xue Yu; Feng Xu; Ying Zhao; Fucheng Sun
Journal:  Front Cardiovasc Med       Date:  2021-04-23

6.  A randomized controlled trial of a physiology-guided percutaneous coronary intervention optimization strategy: Rationale and design of the TARGET FFR study.

Authors:  Damien Collison; John D McClure; Colin Berry; Keith G Oldroyd
Journal:  Clin Cardiol       Date:  2020-02-10       Impact factor: 2.882

7.  Prospective Evaluation of the Strategy of Functionally Optimized Coronary Intervention.

Authors:  Barry F Uretsky; Shiv K Agarwal; Srikanth Vallurupalli; Malek Al-Hawwas; Rimsha Hasan; Kristin Miller; Abdul Hakeem
Journal:  J Am Heart Assoc       Date:  2020-01-30       Impact factor: 5.501

8.  Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes: The FFR-SEARCH Study.

Authors:  Roberto Diletti; Kaneshka Masdjedi; Joost Daemen; Laurens J C van Zandvoort; Tara Neleman; Jeroen Wilschut; Wijnand K Den Dekker; Rutger J van Bommel; Miguel Lemmert; Isabella Kardys; Paul Cummins; Peter de Jaegere; Felix Zijlstra; Nicolas M Van Mieghem
Journal:  Circ Cardiovasc Interv       Date:  2021-03-09       Impact factor: 6.546

Review 9.  Physiologic Assessment after Coronary Stent Implantation.

Authors:  Doyeon Hwang; Seokhun Yang; Jinlong Zhang; Bon Kwon Koo
Journal:  Korean Circ J       Date:  2021-03       Impact factor: 3.243

10.  Prognostic Value of Prerevascularization Fractional Flow Reserve Mediated by the Postrevascularization Level.

Authors:  Rikuta Hamaya; Murray A Mittleman; Masahiro Hoshino; Yoshihisa Kanaji; Tadashi Murai; Joo Myung Lee; Ki Hong Choi; Jun-Jie Zhang; Fei Ye; Xiaobo Li; Zhen Ge; Shao-Liang Chen; Tsunekazu Kakuta
Journal:  JAMA Netw Open       Date:  2020-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.